Press "Enter" to skip to content

Tag: SARS-CoV-2

ACIP member critical of COVID vaccines to lead review

The Centers for Disease Control and Prevention (CDC) vaccine advisory group has long had a work group in place to review the latest COVID-19 vaccine science, including weighing the risks and benefits, but a newly constituted group will launch a sweeping new review of the vaccines led by a member who has opposed COVID vaccines.

The Brownstone Institute on August 22 reported that Retsef Levi, PhD, one of seven members appointed to the Advisory Committee on Immunization Practices (ACIP) by US Health and Human Services (HHS) Secretary Robert F. Kennedy Jr., has been appointed to lead the COVID vaccine review. On August 20, the CDC posted updated terms of reference for the COVID vaccine work group, which is lengthy. Some of the topics include impacts from repeated boosting and mapping policies in other countries.

Levi does not have a biomedical degree or clinical medicine experience. He has a doctorate in operations research and is a professor of operations management at MIT Sloan School of Management. On social media, Levi has called mRNA vaccines dangerous and said they should be removed from the market.

Comments closed

Moderna’s latest COVID-19 vaccine is both approved and ‘made in Canada’

Health Canada has approved Moderna’s newly updated COVID-19 vaccine — and for the first time, the vaccines will be “made in Canada.”

The company says having the vaccine available from domestic manufacturers and suppliers creates a critical piece of health resilience to “ensure Canada is ready, not just reactive.”

“With this approval, for the first time ever, mRNA COVID-19 vaccine doses for Canadians will be made in Canada. That’s a remarkable milestone,” Stefan Raos, general manager at Moderna, says in an emailed statement sent to Global News.

Comments closed

Health Canada approves updated Pfizer, Moderna COVID-19 vaccines for fall

TORONTO – Health Canada has authorized updated COVID-19 vaccines by Pfizer and BioNTech and by Moderna for use this respiratory virus season.

Moderna says it will manufacture vaccine doses for the Canadian market in its new facility in Laval, Quebec and syringes will be filled in Cambridge, Ontario.

News releases from both Pfizer and Moderna say the new mRNA shots will target the LP.8.1 variant, a descendant of Omicron that the World Health Organization was monitoring earlier this year.

Comments closed

Moderna Receives Health Canada Approval for Updated COVID-19 Vaccine Targeting SARS-CoV-2 Variant LP.8.1

All 2025 pre-filled syringe doses to be made in Canada, marking a domestic production milestone

CAMBRIDGE, MA / ACCESS Newswire / August 22, 2025 / Moderna announced today that Health Canada has authorized its updated COVID-19 mRNA vaccine, Spikevax®, targeting the SARS-CoV-2 LP.8.1 variant, for individuals aged six months and older. Moderna is on track to deliver the updated vaccine in time for the 2025-2026 vaccination season.

All Spikevax pre-filled syringe (PFS) doses for the Canadian market will now be manufactured domestically, marking the first time Canada’s entire PFS format is produced at home. The drug substance will be produced at Moderna’s new facility in Laval, Quebec, with fill-finish operations completed by Novocol Pharma in Cambridge, Ontario. These Canadian-made doses are expected to be available for this fall.

“This approval is a regulatory milestone and a testament to Canada’s growing leadership in biomanufacturing and public health resilience,” said Stéphane Bancel, Chief Executive Officer of Moderna. “Thanks to Health Canada’s timely and thorough review, we are proud to supply Spikevax doses to communities across the country, including, for the first time this year, doses produced in Canada.”

Comments closed

Albertans can get COVID-19 vaccinations for free in B.C.

Albertans who don’t qualify for free COVID-19 vaccinations in their home province can get one in British Columbia.

B.C.’s Ministry of Health confirmed that detail in response to a query from CBC News. Canadian residents can get vaccinated due to a reciprocal agreement between all provinces and territories.

“Any publicly funded immunization in B.C. can be provided at no cost to any Canadian travelling within the province,” a statement from the ministry said. “This includes providing publicly funded COVID-19 vaccine to people of Alberta.”

Comments closed

Alberta expands COVID-19 shots coverage for health workers, but calls grow for wider access

Calls are growing louder in Alberta for the COVID-19 vaccine to be covered free of charge for all residents, following the province’s decision Tuesday to partially reverse its vaccine policy and expand coverage to some health-care workers.

While the move has been welcomed by workers and unions, public health experts and critics say it doesn’t go far enough, leaving many Albertans uncertain about access to the vaccine.

“The government has now taken a step towards admitting that they had the wrong approach,” said Chris Galloway, executive director at Friends of Medicare.

Comments closed

Alberta government to cover COVID-19 shots for health-care workers in policy reversal

EDMONTON – In a partial policy reversal, Alberta’s government said Tuesday it will cover the cost of COVID-19 vaccinations for health-care workers.

Maddison McKee, spokesperson to Primary and Preventative Health Services Minister Adriana LaGrange, said in an email that COVID-19 vaccine coverage will be extended to all health-care workers this fall under the first phase of the province’s vaccination rollout.

“Immunization will remain voluntary,” said McKee.

Comments closed

Pfizer Canada and BioNTech Receive Health Canada Approval of LP.8.1 Variant Adapted COVID-19 Vaccine

LP.8.1 variant adapted COVID-19 vaccine COMIRNATY is now authorized in Canada for individuals 6 months of age and older. It is expected to be available in Canada in the coming weeks.

KIRKLAND, QC, Aug. 18, 2025 /CNW/ – Pfizer Canada ULC and BioNTech SE (Nasdaq: BNTX) “BioNTech” announced today that Health Canada has authorized the LP.8.1 variant adapted COMIRNATY® COVID-19 vaccine for individuals aged 6 months and older. The updated COMIRNATY® vaccine targets the Omicron LP.8.1 variant, one of the most recently circulating SARS-CoV-2 lineages.

This season’s Pfizer and BioNTech COVID-19 vaccine will be available in pharmacies across the country in the fall. The public program operates according to the eligibility criteria determined by each province. If an individual meets these criteria, they will be eligible to receive the vaccine for free.

Comments closed

Long COVID left her son with debilitating stomach pain. Why it’s an ‘uphill battle’ for so many kids to get treated

When Rebecca Lewkowicz’s 10-year-old son, Ethan, first tested positive for COVID-19, the Toronto-based mom of two thought little of it — the boy had only minor symptoms, which went away in a matter of days.

She had little reason to suspect the mild infection in April 2022 would soon derail Ethan’s life trajectory and her plans for his future. Nor did she anticipate she would spend more than a year fighting for her son’s illness to be taken seriously.

“We were lucky because it only took us 13 months to be believed,” Lewkowicz told the Star. ”People (living with long COVID) go two, three, four years without being believed, and children even longer.”

Comments closed

Why Canadians with long COVID feel forgotten by the health-care system: ‘The pandemic still isn’t over’

Parts of Tracey Thompson’s home are papered with notes.

Post-its and sheets of paper are pinned to her fridge and bookshelves, chronicling everything from doctor’s appointments to errands and upcoming tasks — physical reminders of what the 57-year-old says her brain can no longer keep track.

Five years after the dawn of the COVID-19 pandemic, Thompson has become one of the faces of long COVID, her journey chronicled by numerous news articles.

“I understand why more folks aren’t willing to be interviewed because they can garner a lot of negative attention,” she told the Star. “While telling my story can feel repetitive and is often stressful, there are still folks who don’t know what’s wrong with them or what the risks are, so I feel obligated to keep talking.”

Her profile may be higher than most, but Thompson is far from alone.

Comments closed

Do you have long COVID? Here’s how to tell, and what we know about the condition so far

It has been more than five years since the dawn of the COVID-19 pandemic, yet innumerable Canadians are still living with the consequences months or even years after their initial infection.

Much remains unknown about long COVID, or Post COVID Condition (PCC), despite the ailment affecting millions of Canadians and leaving thousands out of work. But as research continues to develop, scientists have gleaned some pieces of the puzzle.

Here’s what we know so far about what long COVID is, why it happens and how to tell if you have it.

Comments closed

Funding Changes Might Leave BC’s Long-COVID Patients in the Lurch

Upcoming changes to B.C.’s Medical Services Plan could affect how thousands of long-COVID patients access care.

Starting Sept. 1, MSP is capping all online group medical visits to just 20 patients, to “ensure there can still be a one-on-one interaction between each patient and the attending physician,” the Health Ministry told The Tyee.

Most long-COVID care in B.C. is currently delivered through large online group telehealth sessions from the Bowen Island-based BC Centre for Long COVID, ME/CFS, and Fibromyalgia, or BC-CLMF, which currently has over 5,200 patients — with 25 more referred every day, Dr. Ric Arseneau told The Tyee.

Comments closed

Lab-made sugar-coated particle blocks Covid-19 infection — Possible new treatment on the horizon

Groundbreaking research led by a Swansea University academic has revealed a synthetic glycosystem — a sugar-coated polymer nanoparticle — that can block Covid-19 from infecting human cells, reducing infection rates by nearly 99%.

The glycosystem is a specially designed particle that mimics natural sugars found on human cells. These sugars, known as polysialosides, are made of repeating units of sialic acid — structures that viruses often target to begin infection. By copying this structure, the synthetic molecule acts as a decoy, binding to the virus’s spike protein and preventing it from attaching to real cells.

Unlike vaccines, which trigger immune responses, this molecule acts as a physical shield, offering a novel approach to infection prevention.

Comments closed

RFK Jr.’s war on mRNA vaccines breeds distrust, threatens Canada’s access to development: experts

TORONTO – Canadian doctors and scientists say Robert F. Kennedy Jr.’s defunding of mRNA vaccine research and development projects will have negative health effects in Canada and around the world.

“I think that Canadians do need to understand that this and a lot of the changes that Kennedy is making to vaccination policy in particular are definitely going to affect Canadians,” said Angela Rasmussen, a virologist at the University of Saskatchewan’s Vaccine and Infectious Disease Organization.

Unlike other vaccines, mRNA vaccines can be made very quickly. They can also be easily modified to fight new viruses and adapt to changing strains — something that we saw as new variants emerged during the COVID-19 pandemic, Rasmussen said.

Comments closed

HHS scraps further work on life-saving mRNA vaccine platform

In what experts say will hobble pandemic preparedness, US Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. yesterday announced the dismantling of the country’s mRNA vaccine-development programs—the same innovation that allowed rapid scale-up of COVID-19 vaccines during the public health emergency.

The Biomedical Advanced Research and Development Authority (BARDA) is terminating 22 mRNA vaccine-development contracts totaling just under $500 million, including an award to Moderna/University of Texas Medical Branch for a vaccine against the H5N1 avian flu now sweeping the world. That grant was terminated in late May.

Contracts awarded to Emory University and Tiba Biotech were cancelled, and agreements with Luminary Labs, ModeX, and Seqirus have been scaled back.

Comments closed

RFK Jr. pulls $500 million in funding for vaccine development

WASHINGTON (AP) — The Department of Health and Human Services will cancel contracts and pull funding for some vaccines that are being developed to fight respiratory viruses like COVID-19 and the flu.

Robert F. Kennedy Jr. announced in a statement Tuesday that 22 projects, totaling $500 million, to develop vaccines using mRNA technology will be halted.

Kennedy’s decision to terminate the projects is the latest in a string of decisions that have put the longtime vaccine critic’s doubts about shots into full effect at the nation’s health department. Kennedy has pulled back recommendations around the COVID-19 shots, fired the panel that makes vaccine recommendations, and refused to offer a vigorous endorsement of vaccinations as a measles outbreak worsened.

Comments closed

Alberta’s Perverse New Barriers to COVID Vaccines

Alberta Premier Danielle Smith’s radical new rules for COVID immunization pose a genuine threat to the elderly, the working poor and pregnant moms.

Smith, who revived her ailing political career by peddling conspiratorial COVID theories, has designed a program that is not only punitive but discriminatory, bureaucratic and Soviet in nature.

“This policy is so bad that it’s actually worse than their usual failure to plan properly,” said James Talbot, the province’s former chief medical officer of health. “In fact, it is so bad it looks like they are actually planning to fail.”

Here are the three basic tenets of any successful public health program: make it available, make it accessible and make it affordable. Smith turns all three upside down.

Comments closed